SCHEMBL987150

SCHEMBL987150

COc1cc(C(=O)Cl)cc(OC)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA3 P07451 1/20 0.45
PKM P14618 1/20 0.45
CA5A P35218 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
TPMT P51580 2/20 0.44
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988022 0.90 ALDH1A1 (0.47) LMNACA12CA1CA2CA4
SCHEMBL20873369 0.87 BPTF (0.42) LMNACA12CA1CA2CA4
SCHEMBL11594251 0.83 CA12 (0.67) LMNACA12CA1CA2CA4
SCHEMBL12526814 0.83 LMNA (0.67) LMNACA12CA1CA2CA4
SCHEMBL11789059 0.83 PKM (0.67) LMNACA12CA1CA2CA4
SCHEMBL668639 0.83 RXFP1 (0.56) LMNACA12CA1CA2CA4
SCHEMBL28275397 0.83 TUBB4A (0.55) LMNACYP3A4TSHRTPMTALDH1A1
SCHEMBL219096 0.83 TUBB4A (0.55) LMNACYP3A4TSHRTPMTALDH1A1
SCHEMBL11855711 0.83 CYP3A4 (0.45) LMNACA12CA1CA2CA4
SCHEMBL12331341 0.81 CA12 (0.44) LMNACA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed